We are an international network of healthcare professionals, researchers and consumers preparing, maintaining, and disseminating systematic reviews of randomised control trials for treating cystic fibrosis and other genetic disorders (haemoglobinopathies. coagulopathies and inborn errors of metabolism). Our editorial base is located within the Department of Women's and Children's Health, University of Liverpool and based at the Institute in the Park which is part of Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.

If you are interested in working with us, please go to Join Cochrane.

New podcast on the use of autogenic drainage in cystic fibrosis

An international team have finalised a review of autogenic drainage for airway clearance in people with cystic fibrosis. The lead author, Pam McCormack, has now recorded a podcast presenting the findings of the review which you can listen to here

James Lind Alliance

By getting involved in these priority setting partnerships you can help shape future research. We have already successfully been invovled in a priority setting partnership for CF and you can see the results here. A new priority setting partnership is now open for bleeding disorders and if you have a bleeding disorder and are 8 years of age or older, or if you are a carer for someone with a bleeding disorder, we strongly encourage you to participate. Clinicians and other health professionals are welcome to participate too. More information can be found here.

Latest output published on The Cochrane Library

On Issue 2, 2018 of The Cochrane Library we have published a total of 173 reviews and 25 protocols. There are also 17registered titles currently progressing to protocol status. The production of these reviews involves a network of over 1000 contributors (authors, consumers and referees) throughout the world. We very much welcome interest from new consumers, referees and potential reviewers. Further information can be obtained by contacting the group